We already discussed in this section how the emerging cannabis industry is organizing itself across the Atlantic, creating its own rapidly expanding codes and standards. The leaders are Canada and America, a supremacy that owes nothing to chance since Canada and some American states have accommodating regulations governing the production and consumption of cannabis for therapeutic and recreational use. This new ecosystem is conquering Europe without much ado, a market which it is rumored to be worth several tens of billions of euros according to various forecasters.
Below is a non-exhaustive list of these operations:
April 2019: US giant Tilray inaugurates a production unit in Cantanhede (Portugal) including outdoor and greenhouse crops as well as research laboratories, processing, packaging and distribution sites.
April 2019: Canopy Growth, the industry’s star, acquires the Spanish producer Canamo y Fibras Naturales (Cafina) under license. This is one of the many operations of the Canadian producer, which already has a footprint in Germany, Denmark, the United Kingdom and Poland.
April 2019: Aurora Cannabis is licensed to grow cannabis for medical purposes in Germany. This approval allows the Canadian producer to start construction of a new production unit in Leuna, Germany.
March 2019: Supreme Cannabis is taking steps to obtain a cannabis production license in Malta.
February 2019: Aphria produces its first cannabis strains in Denmark as part of its partnership with the Danish certified company Schroll Medical, a strategic agreement signed in September 2018.
November 2018: The Canadian ICC International Cannabis is expanding its activities in Portugal through the acquisition of the producer Enigma Unipessoal, based in Castelo Branco. A month earlier, Polannabis Holdings of Poland was flying the Canadian flag.